In the latest episode of the Psychedelic Spotlight podcast, we speak with Spencer Hawkswell who is the CEO of TheraPsil, a non-profit coalition of healthcare professionals, patients, and advocates dedicated to obtaining legal access to psilocybin-assisted psychotherapy for Canadians in medical need.In our conversation with Spencer, we discuss the different challenges he and the TheraPsil team are focused on overcoming to increase access to psilocybin-assisted psychotherapy for patients in Canada suffering through end-of-life distress, and why psilocybin, in particular, is capable of offering certain patients relief from their suffering.*To learn more about the company discussed in this episode and the work they’re doing, visit their website: TheraPsil.ca*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on July 20, 2021.